|
Re: two things most believe
|
|
Resverlogix Corp.
|
Sep 08, 2021 06:11PM
|
|
Re: Resverlogix Announces Apabetalone Meets Primary Endpoint in a Pulmonary Arterial Hypertension Pilot Study
|
4
|
Resverlogix Corp.
|
Sep 08, 2021 10:58AM
|
|
AGM
|
3
|
Zenith Epigenetics
|
Sep 08, 2021 10:56AM
|
|
Re: Thoughts on ZCC
|
5
|
Zenith Epigenetics
|
Sep 07, 2021 12:26PM
|
|
Re: As Pfizer charges ahead....
|
5
|
Resverlogix Corp.
|
Sep 04, 2021 12:23PM
|
|
Re: share value/little perspective
|
2
|
Resverlogix Corp.
|
Sep 03, 2021 11:40AM
|
|
Re: share value/little perspective
|
3
|
Resverlogix Corp.
|
Sep 03, 2021 10:53AM
|
|
Re: BETonMACE Cognition Sub-Study Published
|
1
|
Resverlogix Corp.
|
Sep 03, 2021 10:11AM
|
|
Re: share value/little perspective
|
2
|
Resverlogix Corp.
|
Sep 02, 2021 06:36PM
|
|
Thoughts on ZCC
|
6
|
Zenith Epigenetics
|
Sep 02, 2021 12:22PM
|
|
Re: Zenith Shareholders
|
1
|
Zenith Epigenetics
|
Sep 01, 2021 04:48PM
|
|
Re: Zenith Shareholders
|
1
|
Zenith Epigenetics
|
Sep 01, 2021 11:36AM
|
|
Zenith Shareholders
|
2
|
Zenith Epigenetics
|
Aug 31, 2021 08:04PM
|
|
Re: Video presentation from August 25, 2021
|
7
|
Resverlogix Corp.
|
Aug 31, 2021 11:22AM
|
|
Re: So, the mood this week was.
|
1
|
Resverlogix Corp.
|
Aug 28, 2021 09:59AM
|
|
Re: ZEN-3694 in combination with "enzalutamide" in patients with metastatic castration resistant prostate cancer (mCRPC)
|
4
|
Zenith Epigenetics
|
Aug 27, 2021 06:18PM
|
|
Re: So, the mood this week was.
|
2
|
Resverlogix Corp.
|
Aug 27, 2021 05:11PM
|
|
Re: Trillium
|
2
|
Zenith Epigenetics
|
Aug 26, 2021 07:18PM
|
|
Re: So, the mood this week was.
|
1
|
Resverlogix Corp.
|
Aug 26, 2021 12:27PM
|
|
Re: Trillium
|
4
|
Zenith Epigenetics
|
Aug 26, 2021 11:11AM
|
